Table 2. Table showing analytes altered in patients compared with controls.
Molecular function | Analyte | Abbreviation |
Single analyte effects (logistic regression) |
Joint analyte effects (LASSO selection) | |||
---|---|---|---|---|---|---|---|
Coefficient | s.e. | P-value | Adjusted P-value | Coefficient | |||
Lipid transport | Apolipoprotein H | ApoH | 2.67 | 1.05 | 0.011 | 0.032 | 2.23 |
Apolipoprotein A1 | ApoA1 | −1.48 | 0.66 | 0.026 | 0.062 | −0.31 | |
Inflammatory response | Macrophage migration inhibitory factor | MIF | 2.89 | 0.48 | 1.75E−09 | 1.56E−07 | 2.76 |
Carcinoembryonic antigen | CA | 1.77 | 0.36 | 1.13E−06 | 1.68E−05 | 1.69 | |
Tenascin C | TNC | 2.89 | 0.62 | 3.57E−06 | 3.97E−05 | 1.31 | |
Interleukin-10 | IL10 | 3.55 | 0.83 | 1.70E−05 | 1.51E−04 | 3.63 | |
Interleukin-1 receptor antagonist | IL1ra | 1.83 | 0.46 | 6.27E−05 | 4.30E−04 | 0.76 | |
Receptor for advanced glycosylation end products | RAGE | −2.01 | 0.52 | 1.10E−04 | 7.00E−04 | −1.36 | |
Interleukin-8 | IL8 | 2.30 | 0.62 | 2.12E−04 | 1.25E−03 | 0.67 | |
Haptoglobin | HAPT | 1.38 | 0.37 | 2.30E−04 | 1.25E−03 | 1.23 | |
von Willebrand factor | VWF | 1.69 | 0.56 | 0.003 | 0.010 | 1.66 | |
Alpha-2 macroglobulin | A2M | 3.22 | 1.07 | 0.003 | 0.010 | 4.79 | |
Beta-2 microglobulin | B2M | −4.04 | 1.55 | 0.009 | 0.029 | −4.59 | |
Serum glutamic oxaloacetic transaminase | SGOT | 1.90 | 0.83 | 0.022 | 0.055 | 1.67 | |
Interleukin-13 | IL13 | 1.32 | 0.67 | 0.050 | 0.103 | 0.19 | |
Immune system | Immunoglobulin A | IgA | −1.54 | 0.63 | 0.015 | 0.042 | −1.18 |
Hormonal signalling | Pancreatic polypeptide | PPP | 1.97 | 0.34 | 4.12E−09 | 1.83E−07 | 1.80 |
Leptin | Leptin | −1.55 | 0.28 | 5.42E−08 | 1.21E−06 | −0.69 | |
Testosterone (total) | TEST | 2.08 | 0.59 | 4.11E−04 | 0.002 | 0.86 | |
Follicle-stimulating hormone | FSH | 1.17 | 0.34 | 5.19E−04 | 0.002 | 0.33 | |
Thyroid-stimulating hormone | TSH | −1.19 | 0.50 | 0.017 | 0.047 | 0.05 | |
Growth factor signalling | Insulin-like growth factor-binding protein 2 | IGFBP2 | 2.96 | 0.62 | 1.97E−06 | 2.51E−05 | 0.33 |
AXL receptor tyrosine kinase | AXL | −2.35 | 0.82 | 0.004 | 0.014 | −3.93 | |
Stem cell factor | SCF | −2.20 | 0.87 | 0.011 | 0.032 | −1.72 | |
Clotting cascade | Factor VII | FVII | −3.92 | 0.87 | 6.50E−06 | 6.43E−05 | −2.71 |
Angiotensin-converting enzyme | ACE | −1.39 | 0.67 | 0.037 | 0.082 | −1.14 | |
Hormonal signalling | Chromogranin-Aa | CGA | 0.54 | 0.24 | 0.024 | 0.060 | — |
Growth factor signalling | Vascular cell adhesion molecule-1a | VCAM-1 | −2.63 | 1.25 | 0.036 | 0.082 | — |
Inflammatory response | Eotaxina | Eotaxin | 0.98 | 0.48 | 0.041 | 0.087 | — |
The analytes are ranked in the order of significance within each molecular function group.
Not selected by least absolute shrinkage and selection operator (LASSO) regression.